{
    "Trade/Device Name(s)": [
        "VITEK\u00ae 2 AST - Gram Positive Clindamycin",
        "VITEK\u00ae 2 AST - GP Clindamycin"
    ],
    "Submitter Information": "bioM\u00e9rieux, Inc.",
    "510(k) Number": "K122547",
    "Predicate Device Reference 510(k) Number(s)": [
        "K032766"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "October 15, 2012",
    "Summary Letter Received Date": "August 21, 2012",
    "Submission Date": "August 20, 2012",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Antimicrobial Susceptibility Test"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Clindamycin"
    ],
    "Specimen Type(s)": [
        "Isolated colonies"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        "VITEK 2 System",
        "VITEK 2 Compact System"
    ],
    "Method(s)/Technology(ies)": [
        "Antimicrobial susceptibility testing",
        "Minimum inhibitory concentration (MIC) microdilution"
    ],
    "Methodologies": [
        "Automated susceptibility testing",
        "Microdilution methodology"
    ],
    "Submission Type(s)": [
        "Test",
        "Card"
    ],
    "Document Summary": "FDA 510(k) summary for VITEK 2 AST - Gram Positive Clindamycin antimicrobial susceptibility test for Staphylococcus aureus and Staphylococcus epidermidis",
    "Indications for Use Summary": "Quantitative test to determine in vitro susceptibility of Staphylococcus aureus and Staphylococcus epidermidis to clindamycin, for use with VITEK 2 and VITEK 2 Compact Systems",
    "fda_folder": "Microbiology"
}